Skip to main content
Equibles

MetLife Investment Management, LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$174,280
+$46,025 QoQ
Shares Held
152,878
+65.7% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 170 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. AKBA ranks #32 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 512,924 $26,877,217
2 UTHR
UNITED THERAPEUTICS Corp
 20,421 $11,064,710
3 NBIX
Neurocrine Biosciences Inc
 51,732 $8,718,911
4 ZTS
Zoetis Inc.
 108,947 $7,828,931
5 HIMS
Hims & Hers Health, Inc.
 224,462 $7,782,097
6 LNTH
Lantheus Holdings, Inc.
 68,281 $7,575,094
7 ELAN
Elanco Animal Health Inc
 240,384 $5,915,850
8 VTRS
Viatris Inc
 266,382 $4,230,146

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $174,280 152,878
2026-03-31 $128,255 92,270
2025-12-31 $202,024 125,481
2025-09-30 $368,975 135,156
2025-06-30 $545,301 149,808
2025-03-31 $226,874 118,164
2024-12-31 $197,657 104,030
2024-09-30 $89,844 68,064
2024-06-30 $55,240 54,157
2022-03-31 $61,163 85,186
2021-12-31 $69,601 30,797
2021-09-30 $183,530 63,726
2021-06-30 $123,102 32,481
2021-03-31 $206,132 60,896
2020-12-31 $89,868 32,096
2020-09-30 $71,025 28,297
2020-06-30 $790,043 58,177
2020-03-31 $395,873 52,226